{"entity":{"type":"insider","cik":"0001551136","url":"/insider/0001551136","json_url":"/insider/0001551136.json","name":"Baker Bros. Investments, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":640,"n_filings":36,"first":"2013-08-02","last":"2019-04-12","span_basis":"filed_date"},"name_variants":[{"name":"Baker Bros. Investments, L.P.","source":"filing","n_filings":36,"first_seen":"2013-08-02","last_seen":"2019-04-12"}],"transactions":[{"id":8291900,"accession":"0001638599-19-000430","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001638599-19-000430","line_url":"/filing/0001638599-19-000430","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments II, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; 667, L.P.; Baker Brothers Life Sciences LP; Baker Bros. Advisors (GP) LLC; Baker Bros. Investments, L.P.; BAKER JULIAN; 14159, L.P.","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11204.0,"shares_display":"11,204","price_per_share":65.3239,"price_display":"65.32","price_state":"stated","total_value":731888.9756,"total_display":"731,888.98","total_whole":"731,889","shares_owned_after":7639338.0,"shares_owned_after_display":"7,639,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-12","filed_date":"2019-04-12","scope":"insider","n_lines":6},{"id":7989213,"accession":"0001638599-19-000429","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001638599-19-000429","line_url":"/filing/0001638599-19-000429","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments II, L.P.; Baker Bros. Advisors (GP) LLC; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; 14159, L.P.; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":287465.0,"shares_display":"287,465","price_per_share":65.29543715060964,"price_display":"65.30","price_state":"stated","total_value":18770152.8405,"total_display":"18,770,152.84","total_whole":"18,770,153","shares_owned_after":7712345.0,"shares_owned_after_display":"7,712,345","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-12","filed_date":"2019-04-12","scope":"insider","n_lines":12},{"id":7989189,"accession":"0001638599-19-000429","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001638599-19-000429","line_url":"/filing/0001638599-19-000429","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments II, L.P.; Baker Bros. Advisors (GP) LLC; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; 14159, L.P.; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202281.0,"shares_display":"202,281","price_per_share":66.90323116852299,"price_display":"66.90","price_state":"stated","total_value":13533252.504,"total_display":"13,533,252.50","total_whole":"13,533,253","shares_owned_after":7885430.0,"shares_owned_after_display":"7,885,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-11","filed_date":"2019-04-12","scope":"insider","n_lines":12},{"id":8019563,"accession":"0001638599-19-000428","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001638599-19-000428","line_url":"/filing/0001638599-19-000428","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments II, L.P.; BAKER FELIX; Baker Brothers Life Sciences LP; Baker Bros. Advisors (GP) LLC; BAKER BROS. ADVISORS LP; Baker Bros. Investments, L.P.; BAKER JULIAN; 667, L.P.; 14159, L.P.","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13146.0,"shares_display":"13,146","price_per_share":69.1225,"price_display":"69.12","price_state":"stated","total_value":908684.385,"total_display":"908,684.38","total_whole":"908,684","shares_owned_after":8052102.0,"shares_owned_after_display":"8,052,102","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-10","filed_date":"2019-04-10","scope":"insider","n_lines":6},{"id":7959748,"accession":"0001638599-19-000427","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124542.0,"shares_display":"124,542","price_per_share":68.7006,"price_display":"68.70","price_state":"stated","total_value":8556110.1252,"total_display":"8,556,110.13","total_whole":"8,556,110","shares_owned_after":8062934.0,"shares_owned_after_display":"8,062,934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-10","filed_date":"2019-04-10","scope":"insider","n_lines":6},{"id":7959733,"accession":"0001638599-19-000427","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-18","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15543.0,"shares_display":"15,543","price_per_share":67.676,"price_display":"67.68","price_state":"stated","total_value":1051888.068,"total_display":"1,051,888.07","total_whole":"1,051,888","shares_owned_after":8165552.0,"shares_owned_after_display":"8,165,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":7959731,"accession":"0001638599-19-000427","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-17","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2386.0,"shares_display":"2,386","price_per_share":67.676,"price_display":"67.68","price_state":"stated","total_value":161474.936,"total_display":"161,474.94","total_whole":"161,475","shares_owned_after":1295365.0,"shares_owned_after_display":"1,295,365","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":7959729,"accession":"0001638599-19-000427","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-16","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813.0,"shares_display":"1,813","price_per_share":67.8692,"price_display":"67.87","price_state":"stated","total_value":123046.8596,"total_display":"123,046.86","total_whole":"123,047","shares_owned_after":8181095.0,"shares_owned_after_display":"8,181,095","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":7959727,"accession":"0001638599-19-000427","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-15","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":411.0,"shares_display":"411","price_per_share":67.676,"price_display":"67.68","price_state":"stated","total_value":27814.836,"total_display":"27,814.84","total_whole":"27,815","shares_owned_after":255818.0,"shares_owned_after_display":"255,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":7959724,"accession":"0001638599-19-000427","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-14","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":278.0,"shares_display":"278","price_per_share":67.8692,"price_display":"67.87","price_state":"stated","total_value":18867.6376,"total_display":"18,867.64","total_whole":"18,868","shares_owned_after":1297751.0,"shares_owned_after_display":"1,297,751","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":7959722,"accession":"0001638599-19-000427","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-13","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":266.0,"shares_display":"266","price_per_share":67.676,"price_display":"67.68","price_state":"stated","total_value":18001.816,"total_display":"18,001.82","total_whole":"18,002","shares_owned_after":180107.0,"shares_owned_after_display":"180,107","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":7959719,"accession":"0001638599-19-000427","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-12","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239.0,"shares_display":"239","price_per_share":67.676,"price_display":"67.68","price_state":"stated","total_value":16174.564,"total_display":"16,174.56","total_whole":"16,175","shares_owned_after":165595.0,"shares_owned_after_display":"165,595","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":7959716,"accession":"0001638599-19-000427","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001638599-19-000427","line_url":"/filing/0001638599-19-000427#line-11","is_derivative":false,"issuer_cik":"0001087939","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001087939","owner_cik":null,"owner_name":"Baker/Tisch Investments, LP; Baker Bros. Investments, L.P.; BAKER JULIAN; BAKER BROS. ADVISORS LP; 667, L.P.; BAKER FELIX; Baker Bros. Investments II, L.P.; 14159, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP","owner_display_name":"Baker/Tisch Investments, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48.0,"shares_display":"48","price_per_share":67.8692,"price_display":"67.87","price_state":"stated","total_value":3257.7216,"total_display":"3,257.72","total_whole":"3,258","shares_owned_after":256229.0,"shares_owned_after_display":"256,229","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"}],"collapsed":true,"next_cursor":"2019-04-09|7959716","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001131324","name":"GENOMIC HEALTH INC","url":"/issuer/0001131324","role":"Director, Ten percent owner","n_filings":35,"first_seen":"2016-08-15","last_seen":"2019-04-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Ten percent owner","n_filings":1,"first_seen":"2013-08-02","last_seen":"2013-08-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551136","retrieved_at":"2026-08-24T09:43:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}